The effect of gender on the 50% effective dose of remimazolam for facilitating I-gel
Not Applicable
Recruiting
- Conditions
- Not Applicable
- Registration Number
- KCT0007906
- Lead Sponsor
- Ajou University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Adult patients aged 19-65 years with ASA score 1 or 2 scheduled for general anesthesia and eligible for I-gel use
Exclusion Criteria
BMI > 30 kg/m2
Patient refusal
Anticipated difficult airway
Anticipated difficult mask ventilation
COPD, astham, pneumonia, active URI
Risk of aspiration
Patients unable to response on verbal command
History of allergies to benzodiazepines
History of allergies to opioids
History of substance abuse/addiction
Pregnant or breastfeeding patients
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Gender difference in 50% and 95% effective dose of remimazolam for facilitating I-gel with remifentanil target-controlled infusion
- Secondary Outcome Measures
Name Time Method vital signs (blood pressure, heart rate, oxygen saturation), Bispectral index(BIS), loss of consciousness time, I-gel insertion time